No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Adipocytokine signaling pathway 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
2 | Adrenergic signaling in cardiomyocytes 2 genes, 2 drugs (DrugBank) and 6 diseases shown |
2件: ADRB1, ADRB2 |
D00483 |
Propranolol |
5件: 6, 158, 167, 227, 278 |
D08443 |
D00378 |
Timolol |
2件: 157, 227 |
D00603 |
D08600 |
3 | African trypanosomiasis 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
4 | AGE-RAGE signaling pathway in diabetic complications 3 genes, 4 drugs (DrugBank) and 25 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
5 | Allograft rejection 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
6 | Alzheimer disease 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
7 | Amoebiasis 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
8 | Amyotrophic lateral sclerosis (ALS) 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
9 | Antifolate resistance 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
10 | Antigen processing and presentation 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
11 | Apoptosis 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
12 | Asthma 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
13 | Bladder cancer 1 gene, 2 drugs (DrugBank) and 11 diseases shown |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
14 | Breast cancer 2 genes, 2 drugs (DrugBank) and 5 diseases shown |
2件: ESR1, ESR2 |
D00185 |
Estriol |
2件: 13, 227 |
D01986 |
D00966 |
Tamoxifen |
4件: 2, 86, 113, 227 |
D08559 |
15 | C-type lectin receptor signaling pathway 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
16 | Calcium signaling pathway 3 genes, 2 drugs (DrugBank) and 6 diseases shown |
2件: ADRB1, ADRB2 |
D00378 |
Timolol |
2件: 157, 227 |
D00603 |
D08600 |
3件: ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
5件: 6, 158, 167, 227, 278 |
D08443 |
17 | cAMP signaling pathway 3 genes, 3 drugs (DrugBank) and 13 diseases shown |
2件: ADRB1, ADRB2 |
D00483 |
Propranolol |
5件: 6, 158, 167, 227, 278 |
D08443 |
D00378 |
Timolol |
2件: 157, 227 |
D00603 |
D08600 |
1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
D06495 |
18 | Cellular senescence 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
19 | cGMP-PKG signaling pathway 3 genes, 2 drugs (DrugBank) and 6 diseases shown |
2件: ADRB1, ADRB2 |
D00378 |
Timolol |
2件: 157, 227 |
D00603 |
D08600 |
3件: ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
5件: 6, 158, 167, 227, 278 |
D08443 |
20 | Chagas disease (American trypanosomiasis) 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
21 | Complement and coagulation cascades 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: PLG |
D01136 |
Tranexamic acid |
5件: 46, 70, 215, 227, 288 |
22 | Cytokine-cytokine receptor interaction 4 genes, 3 drugs (DrugBank) and 20 diseases shown |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
23 | Cytosolic DNA-sensing pathway 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
24 | Dilated cardiomyopathy (DCM) 2 genes, 4 drugs (DrugBank) and 24 diseases shown |
1件: ADRB1 |
D00483 |
Propranolol |
5件: 6, 158, 167, 227, 278 |
D08443 |
D00378 |
Timolol |
2件: 157, 227 |
D00603 |
D08600 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
25 | EGFR tyrosine kinase inhibitor resistance 2 genes, 3 drugs (DrugBank) and 13 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
26 | Endocrine and other factor-regulated calcium reabsorption 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: ESR1 |
D00185 |
Estriol |
2件: 13, 227 |
D01986 |
D00966 |
Tamoxifen |
4件: 2, 86, 113, 227 |
D08559 |
27 | Endocrine resistance 2 genes, 2 drugs (DrugBank) and 5 diseases shown |
2件: ESR1, ESR2 |
D00185 |
Estriol |
2件: 13, 227 |
D01986 |
D00966 |
Tamoxifen |
4件: 2, 86, 113, 227 |
D08559 |
28 | Epstein-Barr virus infection 4 genes, 3 drugs (DrugBank) and 20 diseases shown |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
29 | Estrogen signaling pathway 2 genes, 2 drugs (DrugBank) and 5 diseases shown |
2件: ESR1, ESR2 |
D00185 |
Estriol |
2件: 13, 227 |
D01986 |
D00966 |
Tamoxifen |
4件: 2, 86, 113, 227 |
D08559 |
30 | Fc epsilon RI signaling pathway 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
31 | Fluid shear stress and atherosclerosis 2 genes, 4 drugs (DrugBank) and 25 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
32 | Focal adhesion 1 gene, 2 drugs (DrugBank) and 11 diseases shown |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
33 | FoxO signaling pathway 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
34 | Gap junction 1 gene, 2 drugs (DrugBank) and 6 diseases shown |
1件: ADRB1 |
D00483 |
Propranolol |
5件: 6, 158, 167, 227, 278 |
D08443 |
D00378 |
Timolol |
2件: 157, 227 |
D00603 |
D08600 |
35 | Gastric acid secretion 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
D06495 |
36 | GnRH secretion 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: ESR2 |
D00185 |
Estriol |
2件: 13, 227 |
D01986 |
D00966 |
Tamoxifen |
4件: 2, 86, 113, 227 |
D08559 |
37 | Graft-versus-host disease 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
38 | Growth hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
D06495 |
39 | Hematopoietic cell lineage 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
40 | Hepatitis B 3 genes, 3 drugs (DrugBank) and 20 diseases shown |
1件: IFNAR1 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
41 | Hepatitis C 3 genes, 3 drugs (DrugBank) and 20 diseases shown |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
42 | Herpes simplex virus 1 infection 4 genes, 3 drugs (DrugBank) and 20 diseases shown |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
43 | HIF-1 signaling pathway 2 genes, 3 drugs (DrugBank) and 13 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
44 | Human cytomegalovirus infection 3 genes, 4 drugs (DrugBank) and 25 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
45 | Human immunodeficiency virus 1 infection 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
46 | Human papillomavirus infection 4 genes, 5 drugs (DrugBank) and 26 diseases shown |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
47 | Human T-cell leukemia virus 1 infection 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
48 | Hypertrophic cardiomyopathy (HCM) 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
49 | IL-17 signaling pathway 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
50 | Inflammatory bowel disease (IBD) 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
51 | Influenza A 5 genes, 4 drugs (DrugBank) and 24 diseases shown |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: PLG |
D01136 |
Tranexamic acid |
5件: 46, 70, 215, 227, 288 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
52 | Insulin resistance 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
53 | Intestinal immune network for IgA production 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
54 | JAK-STAT signaling pathway 3 genes, 2 drugs (DrugBank) and 7 diseases shown |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
55 | Kaposi sarcoma-associated herpesvirus infection 4 genes, 4 drugs (DrugBank) and 14 diseases shown |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
56 | Legionellosis 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
57 | Leishmaniasis 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
58 | Malaria 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
59 | MAPK signaling pathway 2 genes, 4 drugs (DrugBank) and 25 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
60 | Measles 3 genes, 2 drugs (DrugBank) and 7 diseases shown |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
61 | MicroRNAs in cancer 1 gene, 2 drugs (DrugBank) and 11 diseases shown |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
62 | mTOR signaling pathway 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
63 | Natural killer cell mediated cytotoxicity 3 genes, 3 drugs (DrugBank) and 20 diseases shown |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
64 | Necroptosis 3 genes, 3 drugs (DrugBank) and 20 diseases shown |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
65 | Neuroactive ligand-receptor interaction 5 genes, 4 drugs (DrugBank) and 17 diseases shown |
2件: ADRB1, ADRB2 |
D00378 |
Timolol |
2件: 157, 227 |
D00603 |
D08600 |
3件: ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
5件: 6, 158, 167, 227, 278 |
D08443 |
1件: PLG |
D01136 |
Tranexamic acid |
5件: 46, 70, 215, 227, 288 |
1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
D06495 |
66 | NF-kappa B signaling pathway 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
67 | NOD-like receptor signaling pathway 4 genes, 3 drugs (DrugBank) and 20 diseases shown |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
68 | Non-alcoholic fatty liver disease (NAFLD) 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
69 | Osteoclast differentiation 3 genes, 3 drugs (DrugBank) and 20 diseases shown |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
70 | Pancreatic cancer 1 gene, 2 drugs (DrugBank) and 11 diseases shown |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
71 | Pathogenic Escherichia coli infection 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
72 | Pathways in cancer 6 genes, 6 drugs (DrugBank) and 16 diseases shown |
2件: ESR1, ESR2 |
D00185 |
Estriol |
2件: 13, 227 |
D01986 |
D00966 |
Tamoxifen |
4件: 2, 86, 113, 227 |
D08559 |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
73 | Pertussis 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
74 | PI3K-Akt signaling pathway 4 genes, 4 drugs (DrugBank) and 14 diseases shown |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
75 | Prion diseases 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
76 | Prolactin signaling pathway 2 genes, 2 drugs (DrugBank) and 5 diseases shown |
2件: ESR1, ESR2 |
D00185 |
Estriol |
2件: 13, 227 |
D01986 |
D00966 |
Tamoxifen |
4件: 2, 86, 113, 227 |
D08559 |
77 | Proteoglycans in cancer 3 genes, 6 drugs (DrugBank) and 26 diseases shown |
1件: ESR1 |
D00185 |
Estriol |
2件: 13, 227 |
D01986 |
D00966 |
Tamoxifen |
4件: 2, 86, 113, 227 |
D08559 |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
78 | Rap1 signaling pathway 1 gene, 2 drugs (DrugBank) and 11 diseases shown |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
79 | Ras signaling pathway 1 gene, 2 drugs (DrugBank) and 11 diseases shown |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
80 | Regulation of lipolysis in adipocytes 3 genes, 2 drugs (DrugBank) and 6 diseases shown |
2件: ADRB1, ADRB2 |
D00378 |
Timolol |
2件: 157, 227 |
D00603 |
D08600 |
3件: ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
5件: 6, 158, 167, 227, 278 |
D08443 |
81 | Relaxin signaling pathway 1 gene, 2 drugs (DrugBank) and 11 diseases shown |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
82 | Renal cell carcinoma 1 gene, 2 drugs (DrugBank) and 11 diseases shown |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
83 | Renin secretion 3 genes, 2 drugs (DrugBank) and 6 diseases shown |
2件: ADRB1, ADRB2 |
D00378 |
Timolol |
2件: 157, 227 |
D00603 |
D08600 |
3件: ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
5件: 6, 158, 167, 227, 278 |
D08443 |
84 | Rheumatoid arthritis 3 genes, 4 drugs (DrugBank) and 25 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
85 | RIG-I-like receptor signaling pathway 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
86 | Salivary secretion 3 genes, 2 drugs (DrugBank) and 6 diseases shown |
2件: ADRB1, ADRB2 |
D00378 |
Timolol |
2件: 157, 227 |
D00603 |
D08600 |
3件: ADRB1, ADRB2, ADRB3 |
D00483 |
Propranolol |
5件: 6, 158, 167, 227, 278 |
D08443 |
87 | Salmonella infection 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
88 | Shigellosis 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
89 | Sphingolipid signaling pathway 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
90 | Staphylococcus aureus infection 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: PLG |
D01136 |
Tranexamic acid |
5件: 46, 70, 215, 227, 288 |
91 | Systemic lupus erythematosus 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
92 | T cell receptor signaling pathway 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
93 | TGF-beta signaling pathway 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
94 | Th17 cell differentiation 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
95 | Thermogenesis 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: ADRB3 |
D00483 |
Propranolol |
5件: 6, 158, 167, 227, 278 |
D08443 |
96 | Thyroid hormone signaling pathway 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: ESR1 |
D00185 |
Estriol |
2件: 13, 227 |
D01986 |
D00966 |
Tamoxifen |
4件: 2, 86, 113, 227 |
D08559 |
97 | TNF signaling pathway 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
98 | Toll-like receptor signaling pathway 4 genes, 3 drugs (DrugBank) and 20 diseases shown |
2件: IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
3件: 25, 34, 227 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
99 | Toxoplasmosis 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
100 | Transcriptional misregulation in cancer 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
101 | Tuberculosis 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
102 | Type I diabetes mellitus 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
103 | Type II diabetes mellitus 1 gene, 2 drugs (DrugBank) and 19 diseases shown |
1件: TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
104 | VEGF signaling pathway 1 gene, 2 drugs (DrugBank) and 11 diseases shown |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
105 | Viral protein interaction with cytokine and cytokine receptor 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
106 | Yersinia infection 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |